Mild-to-moderate obstructive sleep apnea (AHI 5–30) is treatable with a custom oral device (MAD) that gently advances the lower jaw during sleep to open the airway. An excellent alternative to CPAP for patients who can't tolerate it. We work from a sleep study issued by a sleep-medicine specialist.
The MAD oral device is internationally accepted for: mild-to-moderate sleep apnea (AHI 5–30 on a sleep study), severe primary snoring without apnea, or severe cases (AHI > 30) where the patient cannot tolerate CPAP. The first visit always begins with reviewing your sleep study with a sleep-medicine physician — then we assess jaw and bite suitability.
The device consists of two custom acrylic pieces — one on the upper jaw, one on the lower — connected by hinges that advance the lower jaw 4–8 mm forward. This advancement opens the airway behind the tongue, reduces soft-tissue vibration (the source of snoring), and prevents upper airway collapse.
First visit 60 minutes (sleep study review + jaw exam). 3D iTero scan + impressions. Device delivery in 2–3 weeks, followed by gradual titration over multiple visits (every 2–4 weeks) for 8–12 weeks total. Cost in Jeddah: ~6,000–9,500 SAR including device + titration + 1-year follow-up. Often partially insurance-covered with a documented medical diagnosis.
The device is not suitable for: very severe apnea (AHI > 50) — requires CPAP. Patients with active severe periodontitis. Patients with active TMD (TMD can be treated first, then MAD evaluated). Fewer than 8–10 teeth per arch (insufficient anchorage).